Published in

Rockefeller University Press, Journal of Cell Biology, 4(199), p. 571-575, 2012

DOI: 10.1083/jcb.201208111

Links

Tools

Export citation

Search in Google Scholar

Cell biology: A key driver of therapeutic innovation

Journal article published in 2012 by Oliver Hantschel, Giulio Superti-Furga ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

All processes associated with cellular function are likely to contribute to disease. Particularly in the cancer field, most major therapeutic innovations have originated from the elucidation of basic molecular mechanisms by academic researchers. Recent breakthroughs in molecularly targeted drug discovery have made it clear that it is the depth with which a biological process is understood that empowers its translation. We propose that early, more strategic, support of cutting-edge academic research by industry may be more effective for translational purposes than the current model of a late selection of community-evolved projects.